1Tedesco KL,Rybak MJ. Daptomycin[J]. Pharmacotherapy. 2004,24( 1 ) :41-57.
2Canepari P, Fontana R, Satta G. New targets for the Mechanism of action of antibiotics active against gram-positive cocci [ J ]. J Chemother. 1991,3 Suppl 1 :S141-143.
3Abbanat D, Macielag M, Bush K. Novel antibacterial agents for the treatment of serious Gram-positive infections [ J ]. Expert Opin Investig Drugs. 2003,12(3) :379-399.
4Boaretti M, Canepari P. Purification of daptomycin binding proteins (DBPs)from the membrane of enterococcushirae [ J ]. New Microbiol. 2000,23 ( 3 ):305 -317.
5Silverman JA, Pelmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus [ J ]. Antimicrob Agents Chemother. 2003 ;47 ( 8 ) :2538-2544.
6Braga PC, Ricci D, Da Sasso M. Daptomycin morphostructural damage in Bacillus cereus visualized by atomic force-microscopy[J]. J Chemother. 2002,14(4) :336-341.
7Jevitt lA,Simth AJ, Williams PP, et al. In Vitro activities of daptomycin, linezolid, and quinupristin-dalfopristin against a challenge panel of staphylococci and enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant enterococcus faceium [ J ]. Microb Drug Resist. 2003,9(4) :389-393.
8Streit JM, Jones RN, Sader HS. Daptomycin activity and spectrum: a worldwide sample of 6737 clinical gram-positive organisms [ J ]. J Antimicrob Chemother. 2004,53(4) :669-674.
9Hermsen ED, Hovde LB, HotchkissJR, et al. Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model[ J]. Antimicrob Agents Chemother. 2003,47 ( 12 ): 3764-3767.
10Boaretti M, Canepari P. Purification of daptomycin binding proteins( DB- Ps) from the membrane of enterococcushirae[ J]. New Microbiol,2000, 23(3) :305 -317.
